SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
- PMID: 33622224
- DOI: 10.2174/1566524021666210223143243
SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
Abstract
The proteins of coronavirus are classified as non-structural, structural, and accessory. There are 16 non-structural viral proteins besides their precursors (1a and 1ab polyproteins). The non-structural proteins are named nsp1 to nsp16, and they act as enzymes, coenzymes, and binding proteins to facilitate the replication, transcription, and translation of the virus. The structural proteins are bound to the RNA in the nucleocapsid (N- protein) or to the lipid bilayer membrane of the viral envelope. The lipid bilayer proteins include the membrane protein (M), an envelope protein (E), and spike protein (S). Besides their role as structural proteins, they are essential for the host cells' binding and invasion. The SARS-CoV-2 contains six accessory proteins which participate in the viral replication, assembly and virus-host interactions. The SARS-CoV-2 accessory proteins are orf3a, orf6, orf7a, orf7b, orf8, and orf10. The functions of the SARS-CoV-2 are not well known, while the functions of their corresponding proteins in SARS-CoV are either well known or poorly studied. Recently, the Oxford University and Astrazeneca, Pfizer and BioNTech have made SARS-CoV-2 vaccines by targeting the spike protein gene. The US Food and Drug Administration (FDA) and the health authorities of the United Kingdom have approved and started conducting vaccinations using the Pfizer and BioNTech mRNA vaccine. Also, The FDA of the USA has approved the use of two monoclonal antibodies produced by Regeneron pharmaceuticals to target the spike protein for treating COVID-19. The SARS-CoV-2 proteins can be used for the diagnosis, as drug targets and in vaccination trials for COVID-19. In future COVID-19 research, more efforts should be made to elaborate the functions and structure of the SARS-CoV- 2 proteins so as to use them as targets for COVID-19 drugs and vaccines. Special attention should be paid to extensive research on the SARS-CoV-2 nsp3, orf8, and orf10.
Keywords: SARS-CoV.; nsp3; orf10; orf3; orf8; spike protein.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10. Microbiol Spectr. 2021. PMID: 34756082 Free PMC article.
-
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.Cells. 2021 Apr 6;10(4):821. doi: 10.3390/cells10040821. Cells. 2021. PMID: 33917481 Free PMC article. Review.
-
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8. Nature. 2021. PMID: 33684923
-
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.Cell Rep. 2021 Jul 13;36(2):109391. doi: 10.1016/j.celrep.2021.109391. Epub 2021 Jun 26. Cell Rep. 2021. PMID: 34242574 Free PMC article.
-
Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.Mol Cell Biol. 2021 Aug 24;41(9):e0018521. doi: 10.1128/MCB.00185-21. Epub 2021 Aug 24. Mol Cell Biol. 2021. PMID: 34124934 Free PMC article. Review.
Cited by
-
In Vitro and in Silico Analysis of α -Amylase Inhibitory Activity of Ethanolic Extract of Adhatoda vasica Leaves.Glob Adv Integr Med Health. 2024 Aug 29;13:27536130241270621. doi: 10.1177/27536130241270621. eCollection 2024 Jan-Dec. Glob Adv Integr Med Health. 2024. PMID: 39219710 Free PMC article.
-
A brief review on the lessons learned from COVID-19 on drug discovery and research.Med Pharm Rep. 2024 Jul;97(3):243-248. doi: 10.15386/mpr-2641. Epub 2024 Jul 30. Med Pharm Rep. 2024. PMID: 39234462 Free PMC article. Review.
-
Structural insights into ORF10 recognition by ZYG11B.Biochem Biophys Res Commun. 2022 Aug 6;616:14-18. doi: 10.1016/j.bbrc.2022.05.069. Epub 2022 May 20. Biochem Biophys Res Commun. 2022. PMID: 35636250 Free PMC article.
-
SARS-CoV-2 Spike Protein Interaction Space.Int J Mol Sci. 2023 Jul 27;24(15):12058. doi: 10.3390/ijms241512058. Int J Mol Sci. 2023. PMID: 37569436 Free PMC article.
-
The use of RNA-based treatments in the field of cancer immunotherapy.Mol Cancer. 2023 Jul 7;22(1):106. doi: 10.1186/s12943-023-01807-w. Mol Cancer. 2023. PMID: 37420174 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous